Skip to main content
. 2020 Apr 24;7:70. doi: 10.3389/fmolb.2020.00070

TABLE 1.

Comparison of gallbladder SC/ASC and AC clinicopathological characteristics and XRCC1 expression status.

Clinicopathological characteristics Number of SC/ASC (%) Number of AC (%) P
Gender
 Male 25 (36.2) 61 (41.8) 0.438
 Female 44 (63.8) 85 (58.2)
Age
 ≤45 years 3 (4.3) 20 (13.7) 0.038
 >45 years 66 (95.7) 126 (86.3)
Differentiation
 Well 19 (27.5) 51 (34.9) 0.308
 Moderate 33 (47.8) 54 (37.0)
 Poor 17 (24.6) 41 (28.1)
Maximum tumor diameter
 ≤3 cm 39 (56.5) 90 (61.6) 0.474
 >3 cm 30 (43.5) 56 (38.4)
Cholecystolithiasis
 No 31 (44.9) 78 (53.4) 0.245
 Yes 38 (55.1) 68 (46.6)
TNM stages
 I + II 29 (42.0) 77 (52.7) 0.143
 III + IV 40 (58.0) 69 (47.3)
Lymph node metastasis
 No 27 (39.1) 80 (54.8) 0.032
 Yes 42 (60.9) 66 (45.2)
Locoregional invasion
 No 24 (34.8) 72 (49.3) 0.045
 Yes 45 (65.2) 74 (50.7)
Surgical methods
 Radical 27(39.1) 75 (51.4) 0.223
 Palliative 28 (40.6) 50 (34.2)
 Without resection 14 (20.3) 21 (14.4)
XRCC1
 − 28 (40.6) 58 (39.7) 0.905
 + 41 (59.4) 88 (60.3)

−, negative expression; +, positive expression.